Early Stage Lung Cancer Patients Set for Surgery May Benefit from Opdivo First
News
Opdivo (nivolumab) is a safe and viable option for pre-treating patients with early stage lung cancer before surgery, according to data recently presented during the European Society for Medical Oncology ... Read more